Annual results show sales growth alongside persistent losses. Revenue rose from KRW 12.1 billion in 2022 to KRW 13.1 billion in 2023 (up 8.2%), KRW 13.7 billion in 2024 (up 4.8%), and KRW 16.5 billion in 2025 (up 20.5%).
Over the same period the operating loss was KRW 3.75 billion, KRW 5.99 billion, KRW 5.45 billion and KRW 8.34 billion, with operating margins of -30.9%, -45.7%, -39.6% and -50.4%.
Reports on the first half of 2026 cite R&D spending of KRW 7.4 billion, equal to 80.5% of sales for the period, as a factor keeping losses from narrowing. Net loss attributable to controlling shareholders was KRW 6.33 billion in 2022, KRW 7.52 billion in 2023, KRW 5.82 billion in 2024 and KRW 8.12 billion in 2025.
The debt-to-equity ratio fell from 2,253.3% in 2022 to 146.4% in 2025, but at year-end 2025 controlling shareholders held KRW 8.68 billion of KRW 16.7 billion total equity, so the rest is non-controlling interest.
Operating cash flow was negative in all four years, at -KRW 3.21 billion, -KRW 6.15 billion, -KRW 3.5 billion and -KRW 3.98 billion.
Quarterly sales rose to KRW 4.03 billion in the fourth quarter of 2025 (up 24.3% from the prior quarter), then to KRW 4.4 billion and KRW 4.82 billion in the first and second quarters of 2026, before falling 22.4% to KRW 3.74 billion in the third quarter, still up 15.1% year on year.
The operating loss peaked at KRW 3.69 billion in the second quarter of 2026 and narrowed to KRW 2.85 billion in the third quarter.
The second-quarter 2026 net loss attributable to controlling shareholders of KRW 6.84 billion was the largest of the five quarters, and the four-quarter total from the fourth quarter of 2025 to the third quarter of 2026 is KRW 12.9 billion.
In the fourth quarter of 2025 the operating loss was KRW 2.68 billion while the controlling-shareholder net loss was only KRW 501 million, a wide gap between the two measures.